Global Barrett’s Esophagus Market Size, Share, and COVID-19 Impact Analysis, By Type (No Dysplasia, Low-Grade Dysplasia, High-Grade Dysplasia, Others), By Diagnosis (Endoscopy, Biopsy, & Others), By Treatment (Medication, Endoscopic Therapy, Surgery, & Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, & Others) By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032

Industry: Healthcare


Global Barrett’s Esophagus Market Insights Forecasts to 2032

  • The Global Barrett’s Esophagus Market Size was valued at USD 6.7 billion in 2022.
  • The market is growing at a CAGR of 6.4% from 2022 to 2032.
  • The worldwide Barrett’s Esophagus Market size is expected to reach USD 12.5 billion by 2032.
  • Asia Pacific is expected to grow the fastest during the forecast period.



Barrett’s Esophagus Market

Get more details on this report -

Request Free Sample PDF

The Global Barrett’s Esophagus Market Size is expected to reach USD 12.5 billion by 2032, at a CAGR of 6.4% during the forecast period 2022 to 2032.


Market Overview

A potentially harmful effect of gastroesophageal reflux disease (GERD) is Barrett's esophagus. In Barrett's esophagus, the normal tissue lining the esophagus (the tube that carries food from the mouth to the stomach) changes into tissue that mimics the gut lining. 10% of people with long-term GERD symptoms have Barrett's esophagus. Patients with Barrett's esophagus may suffer GERD symptoms even though the condition has no specific symptoms. Intestinal cells in Barrett's esophagus are more acid-resistant than squamous cells, suggesting that the tissue changes take place to shield the esophagus from acid exposure. Men are more likely than women to have this condition, and white individuals are more likely to have it than Hispanic people. In Asian and Black individuals, it is unusual. BE increases the chance of esophageal cancer in those who are suffering from this condition. To avoid malignancy and enhance patient outcomes, Barrett's esophagus with dysplasia must be managed effectively. The available treatments for BE with dysplasia vary on the degree of dysplasia as well as the patient's age, concomitant conditions, and preferences. The market for treating Barrett's esophagus with dysplasia comprises many pharmaceuticals and medical equipment utilized for endoscopic treatments, including photodynamic therapy agents, endoscopic mucosal resection tools, and radiofrequency ablation catheters.


Report Coverage

This research report categorizes the global Barrett’s esophagus market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global Barrett’s esophagus market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global Barrett’s esophagus market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.


Global Barrett’s Esophagus Market Report Coverage

Report CoverageDetails
Base Year:2022
Market Size in 2022:USD 6.7 billion
Forecast Period:2022 - 2032
Forecast Period CAGR 2022 - 2032 :6.4%
2032 Value Projection:USD 12.5 billion
Historical Data for:2018 - 2021
No. of Pages:212
Tables, Charts & Figures:124
Segments covered:By Type, By Diagnosis, By Treatment, By Distribution, Channel, By Region
Companies covered::GlaxoSmithKline plc, Novartis AG, Bayer AG, Eli Lilly and Company, Merck & Co., Inc., AstraZeneca, Johnson & Johnson Private Limited, Cipla Inc., Abbott, AbbVie Inc., Merck KGaA , Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., Sanofi, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, Procter & Gamble, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd.

Get more details on this report -

Request Free Sample PDF

Driving Factors

The growing cost of healthcare aids in enhancing its infrastructure. The market dynamics will also be driven by different government organizations' efforts to strengthen the healthcare infrastructure by boosting financing. Also, ongoing acid reflux and persistent heartburn are expected to have an impact on the market for Barrett's esophagus. If your GERD is severe enough to require daily medication or if it doesn't get better when you take proton pump inhibitors, you are more likely to develop Barrett's esophagus. Moreover, the market for Barrett's esophagus will also grow as a result of growing efforts by both governmental and private groups to raise awareness of thyroid conditions and family history. The market for Barrett's esophagus will also grow as a result of growing disposable income and an increase in the number of GERD patients. Furthermore, according to estimates, the market for Barrett's esophagus will expand faster due to people's constantly evolving lifestyles. The market is anticipated to grow as a result of rising alcohol intake and obesity rates, both of which raise the risk of Barrett's esophagus and GERD in humans. Additionally, a risk factor for Barrett's esophagus that is expanding in prevalence is increasing smoking addiction, which may influence market dynamics during the projection period.


Restraining Factors

The high cost of the therapy will hinder the market's rate of expansion. Barrett's esophagus market will face challenges due to a shortage of qualified workers and a lack of healthcare infrastructure in emerging nations. Furthermore, the absence of a disease etiology and low levels of public awareness may constrain and hinder the market's growth rate throughout the projection period. Moreover, the regulatory requirements for approval of new treatments for Barrett's esophagus with dysplasia can be stringent, which can limit the number of treatments that make it to market. This can impact the availability of new and innovative treatments for patients.


Market Segmentation

  • In 2022 the high-grade dysplasia segment is dominating the market with the largest market share during the forecast period.

Based on the type, the global barrett’s esophagus market is segmented into various segments including no dysplasia, low-grade dysplasia, high grade dysplasia, and others. Among these segments, the high-grade dysplasia segment holds the largest market share during the forecast period. High-grade dysplasia indicates the presence of more severe cellular abnormalities in the tissue samples. The abnormal cells exhibit significant disorganization and resemble cancer cells but have not yet invaded the deeper layers of the esophagus. High-grade dysplasia is considered a significant risk factor for the development of esophageal cancer. Treatment options may include endoscopic therapy or surgical intervention to remove or destroy the abnormal tissue.


  •  In 2022, endoscopic therapy is influencing the largest market growth during the forecast period.

Based on the treatment, the global barrett’s esophagus market is bifurcated into several subsectors including medication, endoscopic therapy, surgery, & others. Among these, endoscopic therapy is dominating the segment. Endoscopic treatments are minimally invasive procedures performed during an endoscopy to remove or destroy abnormal cells in the esophagus. These may include techniques like radiofrequency ablation (RFA), photodynamic therapy (PDT), or cryotherapy.


  • In 2022, the hospital pharmacy segment is holding the largest market share during the forecast period.

Based on the distribution channel, the global barrett’s esophagus market is divided into segments such as hospital pharmacy, retail pharmacy, online pharmacy, & others. Among these, the hospital pharmacy segment holds the highest market during the forecast period. Hospital pharmacies play a critical role in the management of Barrett's esophagus, as they are often the first point of contact for patients with Barrett's esophagus. Hospital pharmacies provide access to a wide range of medications and specialized treatment options, including invasive procedures and advanced imaging techniques, which are essential for the management of Barrett's Esophagus.


Regional Segment Analysis of the global barrett’s esophagus market

  • North America (U.S., Canada, Mexico)  
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)


North America dominates the market with the largest market share during the forecast period


Barrett’s Esophagus Market

Get more details on this report -

Request Free Sample PDF

North America is dominate the market for global Barrett's esophagus, due to the region's increased rates of obesity, gastric imbalance illnesses, and medical spending. Major important companies' presence in this area will also further accelerate the market's growth rate. Furthermore, North America has an established healthcare infrastructure, with access to cutting-edge medical technology and well-trained healthcare professionals. This has made it easier to develop and spread novel therapies for Barrett's esophagus.


Asia-Pacific is anticipated to expand throughout the projected period as a result of the region's rising obesity incidence and a growing number of generic manufacturers. The expansion of the healthcare sector and the widespread use of alcohol in developed nations will also contribute to the region's market's rapid expansion.


 Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the global barrett’s esophagus market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.


List of Key Companies

  • GlaxoSmithKline plc
  • Novartis AG
  • Bayer AG
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Cipla Inc.
  • Abbott
  • AbbVie Inc.
  • Merck KGaA
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • Dr. Reddy’s Laboratories Ltd.
  • Pfizer Inc.
  • Sanofi
  • F. Hoffmann-La Roche Ltd.
  • Boehringer Ingelheim International GmbH
  • Procter & Gamble
  • Takeda Pharmaceutical Company Limited
  • Eisai Co., Ltd.


Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)


Recent Development

  • In August 2022, New Barrett's esophagus guidelines published by the American College of Gastroenterology recommend expanding screening techniques beyond endoscopic procedures, upping the frequency of short-segment Barrett's esophageal surveillance, and implementing volume criteria for endoscopic therapy facilities.


Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global Barrett’s Esophagus Market based on the below-mentioned segments:


Global Barrett’s Esophagus Market, By Type

  • No Dysplasia
  • Low-Grade Dysplasia
  • High-Grade Dysplasia
  • Others


Global Barrett’s Esophagus Market, By Diagnosis

  • Endoscopy
  • Biopsy
  • Others


Global Barrett’s Esophagus Market, By Treatment

  • Medication
  • Endoscopic Therapy
  • Surgery
  • Others


Global Barrett’s Esophagus Market, By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others


Barrett’s Esophagus Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico 
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies